XRAY
Undervalued by 146% based on the discounted cash flow analysis.
Market cap | $3.18 Billion |
---|---|
Enterprise Value | $5.56 Billion |
Dividend Yield | $0.64 (4.00500625782228%) |
Earnings per Share | $-4.48 |
Beta | 0.94 |
Outstanding Shares | 199,100,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -3.5 |
---|---|
PEG | -31.54 |
Price to Sales | 0.88 |
Price to Book Ratio | 1.59 |
Enterprise Value to Revenue | 1.49 |
Enterprise Value to EBIT | -17.82 |
Enterprise Value to Net Income | -7 |
Total Debt to Enterprise | 0.5 |
Debt to Equity | 1.38 |
No data
No data